Sun Pharmaceutical Industries shareholding pattern

As of 08-2026, the promoter shareholding in Sun Pharmaceutical Industries stands at 54.48% of the company's total shares. Promoter shareholding represents the ownership stake held by the company's founding members, management, or controlling entities, having a significant influence on the company's strategic direction and operations.

The FII and DII shareholding of Sun Pharmaceutical Industries is 14.54% and 2.3% respectively.

The retail shareholding of the Sun Pharmaceutical Industries is 8.82%.

Changes in shareholding patterns of Sun Pharmaceutical Industries can result from stock market transactions, issuance of new shares, buybacks, mergers, acquisitions, or changes in promoter holdings.

Shareholding patterns of Sun Pharmaceutical Industries are updated quarterly as mandated by regulatory authorities and may also be disclosed during significant corporate events.

The latest shareholding pattern is available on stock exchanges (e.g., NSE, BSE) and the company's official website under investor relations.